Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2026-03-30 00:00:00 ET · period of report 2026-03-27 · accession 0001706176-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-27 | LENZ | Chevallard Daniel R. | CFO | P - Purchase | $8.57 | +7,500 | 12.9K | +139% | +$64.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-27 | P | A | 7,500 | $8.57 | 12,886 | D | — | — |